Wexford Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,791
Closed -$251K 172
2017
Q3
$251K Buy
4,791
+1,091
+29% +$60.8K 0.02% 137
2017
Q2
$216K Buy
+3,700
New +$192K 0.02% 163

Other funds holding SYNH

Wexford Capital's SYNH Position: Q4 2017 in Review

Wexford Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 4,791 shares — an estimated $251K sold.

Wexford Capital first reported a position in SYNH in Q2 2017 and held it in 2 quarters. The position peaked at $251K in Q3 2017. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Wexford Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
  • Wexford Capital sold 4,791 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $251K.
  • Wexford Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 2 quarters.
  • Wexford Capital's Syneos Health, Inc. Class A Common Stock position peaked at $251K in Q3 2017.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Wexford Capital's 13F filing for Q4 2017, filed 13 Feb 2018.